|
Sign In to gain access to subscriptions and/or personal tools.
|
Cytokines and Their Role in the Pathophysiology of Cancer Cachexia
Michael J. Mcnamara, MD
Surgical Metabolism Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
H. Richard Alexander, MD
Surgical Metabolism Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Jeffrey A. Norton, MD
Washington Uniuersity School of Medicine, St Louis
Cancer cachexia describes a syndrome that consists of weight loss, and abnormalities in carbohydrate, protein, and lipid metabolism, which result in a state of persistent net negative energy balance. Patients suffering from cancer cachexia have a significantly shortened survival after cancer treatment. Recent experimental studies have focused on the belief that the mechanisms of cancer cachexia involve the host's production of inflammatory cytokines, which through broad physiologic actions ultimately lead to a chronic state of wasting, malnourishment, and death. Cytokines that have been thought to play a role in the pathophysiology of cachexia include tumor necrosis factor, interleukin-1, interleukin-6, interferon- and differentiation factor. It has become clear that these cytokines have overlapping physiologic activities, which makes it likely that no single substance is the sole cause of cachexia in most cancer patients. Only further investigation may make it possible to more clearly define the role of cytokines in the pathophysiology of cancer cachexia. Specific strategies to reverse the cachectic effects of these substances may then be developed to ultimately improve cancer treatment. (Journal of Parenteral and Enteral Nutrition 16:50S-55S)
Journal of Parenteral and Enteral Nutrition, Vol. 16, No. 6 Suppl,
50S-55S (1992)
DOI: 10.1177/014860719201600603

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. H. V. Remels, R. C. J. Langen, H. R. Gosker, A. P. Russell, F. Spaapen, J. W. Voncken, P. Schrauwen, and A. M. W. J. Schols
PPAR{gamma} inhibits NF-{kappa}B-dependent transcriptional activation in skeletal muscle
Am J Physiol Endocrinol Metab,
July 1, 2009;
297(1):
E174 - E183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Shang, C. Weiss, S. Post, and G. Kaehler
The Influence of Early Supplementation of Parenteral Nutrition on Quality of Life and Body Composition in Patients With Advanced Cancer
JPEN J Parenter Enteral Nutr,
May 1, 2006;
30(3):
222 - 230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Hardin
Invited Review: Cytokine Mediators of Malnutrition: Clinical Implications
Nutr Clin Pract,
April 1, 1993;
8(2):
55 - 59.
[Abstract]
[PDF]
|
 |
|
|
|